ABMYVO
DEAD

Serial Number

98264911

Owner

Reneo Pharmaceuticals, Inc.

Attorney

Brian Focarino

Filing Date

Nov 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ABMYVO Trademark

Serial Number: 98264911

ABMYVO is a trademark filed by Reneo Pharmaceuticals, Inc. on November 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Reneo Pharmaceuticals, Inc. (4 trademarks)

Irvine, CA 92612

Entity Type: 03

Trademark Details

Filing Date

November 10, 2023

Registration Date

Not Registered

Published for Opposition

July 23, 2024

Goods & Services

Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of liver and kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 20, 2024 ETOP
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Sep 17, 2024 MAB5
ABANDONMENT - AFTER PUBLICATION
Sep 17, 2024 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Sep 16, 2024 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 16, 2024 ETOF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 15, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 15, 2024 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2023 NWOS
NEW APPLICATION ENTERED
Nov 14, 2023 NWAP